β-amyloid plaques: Stages in life history or independent origin?

Dementia and Geriatric Cognitive Disorders

Volumn 9, Issue 4, 1998, Pages 227-238

  Armstrong, R A ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

amyloid; Alzheimer's disease; Independent origin; Life history; Senile plaque

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; DOWN SYNDROME; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE;

ALZHEIMER DISEASE; BRAIN; DISEASE PROGRESSION; DOWN SYNDROME; HUMANS; SENILE PLAQUES; TERMINOLOGY;

EID: 0031811820     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017051     Document Type: Review

References (128)

1. Deláere P, Duyckaerts C, He Y, Piette F, Hauw JJ: Subtypes and differential laminar distributions of β/A4 deposits in Alzheimer's disease: Relationship with the intellectual status of 26 cases, Acta Neuropathol 1991;81:328-335.
2. Spargo E, Luthert PJ, Janota I, Lantos PL: β/A4 deposition in the temporal cortex of adults with Down's syndrome. J Neural Sci 1992;111:26-32.
3. Armstrong RA: Relationships between morphological types of plaque in Alzheimer's disease as revealed in silver and immunostained preparations. Neurodegeneration 1993;2:259-266.
4. Armstrong RA: Differences in β-amyloid (β/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease. Neurosci Lett 1994;169:133-136.
5. Greenberg BD: The COOH-terminus of the Alzheimer amyloid Aβ peptide: Differences in length influence the process of amyloid deposition in Alzheimer brain, and tell us something about relationships among parenchymal and vessel-associated amyloid deposits. Amyloid 1995;21:195-203.
6. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Igbal K: Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 1993;301:41-52.
7. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Coffer RJ, Reardon IM, Zurcher-Neely HA, Heinrikson RL, Ball MJ, Greenberg BD: Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993;268:3072-3083.
8. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Rocques P, Hardy J, Mullan M: Early onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991;353:844-846.
9. Goate R, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak- Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature (Lond) 1991;349:704-706.
10. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL: Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 1990;248:492-495.
11. Rumble B, Retallack R, Hilbich C, Simms C, Mulhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL: Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 1989;320:1446-1452.
12. Oyama O, Cairns NJ, Shimada H, Oyama R, Titani K, Ihara Y: Down's syndrome: Up-regulation of β-amyloid protein precursor and τ mRNAs and their defective coordination. J Neurochem 1994;62:1062-1066.
13. 717) mutants. Science 1994;264:1336-1340.
14. Wisniewski HM, Bancher C, Barcikowska M, Wen GY, Curree J: Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathol 1989;78:337-347.
15. Itoh Y, Yamada M, Hayakawa M, Otonio E, Miyatake T: Subpial β/A4 peptide deposits are closely associated with amyloid angiopathy in the elderly. Neurosci Lett 1993;155:144-147.
16. Armstrong RA, Myers D, Smith CUM: The spatial patterns of β/A4 deposits in Alzheimer's disease. Acta Neuropathol 1993;86:36-41.
17. Brun A: An overview of light and electron microscope changes; in Reisberg B (ed): Alzheimer's Disease. The Standard Reference. London, MacMillan 1983, pp 37-45.
18. Rozemuller JM, Eikelenboom P, Stam FC, Beyreuther K, Masters CL: A4 protein in Alzheimer's disease: Primary and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol 1989;48:674-691.
19. Ikeda SI, Nobuo MD, Yanagisawa MB, Allsop D, Glenner GG: Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry and electron microscopy. Hum Pathol 1990;21:1221-1226.
20. Tagliavini F, Giaccone G, Frangione B, Bugiani O: Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and non demented individuals. Neurosci Lett 1988;93:191-196.
21. Allsop D, Haga S, Ikeda SI, Mann DMA, Ishii T: Early senile plaques in Down's syndrome brains show a close relationship with cell bodies of neurons. Neuropathol Appl Neurobiol 1989;15:531-542.
22. Perry G: Neuritic plaques in Alzheimer's disease originate from neurofibrillary tangles. Med Hypotheses 1993;40:257-258.
23. Halliday G, Flowers D, Baura L: Analysis of staining methods for different cortical plaques in Alzheimer's disease. Acta Neuropathol 1994;87:174-186.
24. Miyakawa T, Katsuragi S, Yamashiba K, Ohuchi K: Morphological study of amyloid fibrils and preamyloid deposits in the brain with Alzheimer's disease. Acta Neuropathol 1992;83:340-346.
25. Bugiani O, Giaccone G, Frangione B, Ghetti B, Tagliavini F: Alzheimer patients: Preamyloid deposits are more widely distributed than senile plaques throughout the central nervous system. Neurosci Lett 1989;103:263-268.
26. Iwatsubo T, Odaka A, Suzuki N, Myusawa H, Nukima N, Ihara Y: Visualisation of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43). Neuron 1994;13:45-53.
27. Tagliavini F, Giaccone G, Verga L, Ghiso L, Frangione B, Bugiani O: Alzheimer's patients: preamyloid deposits are immunoreactive with antibodies to extracellular domains of amyloid precursor protein. Neurosci Lett 1991;128:117-120.
28. Yamaguchi H, Nakazato Y, Hirai S, Shoji M, Harigaya Y: Electron micrograph of diffuse plaques: Initial stage of senile plaque formation in the Alzheimer brain. Am J Pathol 1989;135:593-597.
29. Yamaguchi H, Nakazato Y, Shoji M, Takatama M, Hirai S: Ultrastructure of diffuse plaques in senile dementia of the Alzheimer type: Comparison with primitive plaques. Acta Neuropathol 1991;82:13-20.
30. Akiyama H, Tago H, Itagaki S, McGeer PL: Occurrence of diffuse amyloid deposits in the presubicular parvopyramidal layer in Alzheimer's disease. Acta Neuropathol 1990;79:537-544.
31. Mann DMA, Jones D, Prinja D, Purkiss MS: The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease. Acta Neuropathol 1990;80:318-327.
32. Ihara Y: What mediates between β-amyloid and paired helical filaments. Neurobiol Ageing 1989;10:573-574.
33. Schmidt ML, DiDario AG, Lee VM, Trojanowski JQ: An extensive network of PHF τ-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer's disease. FEBS Lett 1994;344:69-73.
34. Rifenburg RP, Perry G: Dystrophic neurites define diffuse as well as core-containing senile plaques in Alzheimer's disease. Neurodegeneration 1995;4:235-237.
35. Papolla MA, Omar RA, Vinters HV: Image analysis microspectroscopy shows that neurons participate in the genesis of a subset of early primitive (diffuse) senile plaques. Am J Pathol 1991;139:599-607.
36. Cummings BJ, Su JH, Cotman CW, White R, Russell MJ: β-Amyloid accumulation in aged canine brain: A model of early plaque formation in Alzheimer's disease. Neurobiol Ageing 1993;14:547-560.
37. Armstrong RA: Factors determining the morphology of β-amyloid (Aβ) deposits in Down's syndrome. Neurodegeneration 1995;4:179-186.
38. Wujek JR, Dority MD, Frederickson RCA, Brunden KR: Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro. Neurobiol Ageing 1996;17:107-113.
39. Mann DMA, Jones D, South PW, Snowden JS, Neary D: Deposition of amyloid β protein in non-Alzheimer dementias: Evidence for a neuronal origin of parenchymal deposits of β protein in neurodegenerative disease. Acta Neuropathol 1992;83:415-419.
40. Armstrong RA, Myers D, Smith CUM: What determines the size frequency distribution of β-amyloid (Aβ) deposits in Alzheimer's disease patients? Neurosci Lett 1995;187:13-16.
41. Benes FM, Reifel JL, Majocha RE, Marotta CA: Evidence for a diffusional model of Alzheimer amyloid A4 (β-amyloid) deposition during neuritic plaque formation. Neuroscience 1989;33:483-488.
42. Hachini KH, Verga L, Giaccone G, Tagliavini F, Frangione B, Bugiani O, Foncin JF: Relationship between non-fibrillary amyloid precursors and cell processes in the cortical neuropil of Alzheimer patients. Neurosci Lett 1991;129:119-122.
43. Shimada A, Kuwamura M, Umemura T, Takada K, Ohama E, Itakura C: Modified Bielschowsky and immunohistochemical studies on senile plaques in aged dogs. Neurosci Lett 1991;129:25-28.
44. Ohgami T, Kitamoto T, Weidmann A, Beyreuther K, Takeishi J: Alzheimer's amyloid precursor protein-positive degenerative neurites exist even within Kuru plaques not specific to Alzheimer's disease. Am J Pathol 1991;139:1245-1250.
45. Griffin WST, Shen JG, Roberts GW, Mrak ME: Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol 1995;54:276-281.
46. Yamaguchi H, Ishiguro K, Sugihara S, Nakazato Y, Kawarabayashi T, Sun X, Hirai S: Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition. Acta Neuropathol 1994;88:413-419.
47. Verga L, Frangione B, Tagliavini F, Giaccone G, Migheli A, Bugiani O: Alzheimer and Down's patients: Cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques. Neurosci Lett 1989;105:294-299.
48. Kalaria RN, Perry G: Amyloid P component and other acute-phase proteins associated with cerebellar deposits in Alzheimer disease. Brain Res 1993;631:151-155.
49. Edwards RJ, Clinton J, Gentleman SM, Roberts GW, Roystan MC: Classification and quantification of plaque types in Alzheimer's disease using computerised image analysis. Neurodegeneration 1992;1:65-71.
50. Clinton J, Roberts GW, Gentleman SM, Roystan MC: Differential pattern of β-amyloid protein deposition within cortical sulci and gyri in Alzheimer's disease. Neuropathol Appl Neurobiol 1993;19:277-281.
51. McKenzie IRA: Senile plaques do not progressively accumulate with normal ageing. Acta Neuropathol 1994;87:520-525.
52. Svenaga T, Hirano A, Llena JF, Yen SH, Dickson DW: Modified Bielschowsky stain and immunohistochemical studies on striatal plaques in Alzheimer's disease. Acta Neuropathol 1990;80:280-286.
53. 1-42/43) in cerebellar diffuse plaques: Enzyme linked immunosorbent assay and immunoctochemical study. Brain Res 1995;679:151-156.
54. Mann DMA, Esiri MM: The pattern of acquisition of plaques and tangles in the brain of patients under 50 years of age with Down's syndrome. J Neurol Sci 1989;89:169-179.
55. Mann DMA, Younis N, Jones D, Stoddart RW: The time course of the pathological events in Down's syndrome with particular reference to the involvement of microglial cells and deposits of β/A4. Neurodegen 1992;1:201-215.
56. Sparks DL, Hunsaker JC: Down's syndrome: Occurrence of Alz-50 reactive neurons and the formation of senile plaques. J Neurol Sci 1992;109:77-82.
57. Gibson PH: Ultrastructural abnormalities in the cerebral neocortex and hippocampus associated with Alzheimer's disease and ageing. Acta Neuropathol 1987;73:86-91.
58. Beach TG, McGeer EG: Senile plaques, amyloid β-protein and acetylcholinesterase fibers: Laminar distributions in Alzheimer's disease striate cortex. Acta Neuropathol 1992;83:292-299.
59. Armstrong RA: The spatial patterns of β/A4 deposit subtypes in Down's syndrome. Acta Neuropathol 1994;88:353-358.
60. Tourtellote WG, van Hoesen GW: The axonal origin of a subpopulation of dystrophic neurites in Alzheimer's disease. Neurosci Lett 1991;129:11-16.
61. Adams LA, Munoz DG: Differential incorporation of processes derived from different classes of neurons into senile plaques in Alzheimer's disease, Acta Neuropathol 1993;86:365-370.
62. Struble RG, Powers RE, Casanova MF, Kitt CA, Brown EC, Price DL: Neuropeptidergic systems in plaques of Alzheimer's disease. J Neuropathol Exp Neurol 1987;46:567-584.
63. Munoz DG, Wang D: Tangle-associated neuritic clusters: A new lesion in Alzheimer's disease and ageing suggests that aggregates of dystrophic neurites are not necessarily associated with β/A4. Am J Pathol 1992;140:1167-1178.
64. He Y, Deléere P, Duychaerts C, Wasowicz M, Piette F, Hauw JJ: Two distinct ubiquitin immunoreactive senile plaques in Alzheimer's disease: Relationship with the intellectual status in 29 cases. Acta Neuropathol 1993;86:109-116.
65. Yasuhara O, Kawamata T, Aimi Y, McGeer EG, McGeer PL: Two types of dystrophic neurites in senile plaques of Alzheimer's disease and elderly non-demented cases. Neurosci Lett 1994;171:73-76.
66. Sheng JG, Mrak RE, Griffin WST: S100β protein expression in Alzheimer's disease: Potential role in the pathogenesis of neuritic plaques. J Neurosci Res 1994;39:398-404.
67. Pike CJ, Cummings BJ, Cotman CW: Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp Neurol 1995;132:172-179.
68. Armstrong RA, Smith CUM: β-amyloid (β/A4) deposition in the medial temporal lobe in Down's syndrome: Effects of brain region and patient age. Neurobiol Dis 1994;1:139-144.
69. Rafalowska J, Barcikowska M, Wen GY, Wisniewski HM: Laminar distribution of neuritic plaques in normal ageing, Alzheimer's disease and Down's syndrome. Acta Neuropathol 1988;77:21-25.
70. Armstrong RA: β-amyloid (Aβ) deposits and blood vessels: Laminar distribution in the frontal cortex of patients with Alzheimer's disease. Neurosci Res Commun 1996;18:29-28.
71. Barrow CJ, Zagorski MG: Solution structure of β-peptide and its constituent fragments: relation to amyloid deposition. Science 1991;253:179-182.
72. Arai H, Lee VM, Otvos L, Greenbcrg BD, Lowery DE, Sharma SK, Schmidt ML, Trojanowski JQ: Defined neurofilament T and β-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc Natl Acad Sci USA 1990;87:2249-2253.
73. Wisniewski HM: Neuritic (senile) and amyloid plaques: in Reisberg B (ed): Alzheimer's Disease: The Standard Reference. London. MacMillan, 1983, pp 57-61.
74. Powers JM, Schlaepfer WW, Willingham MC, Hall BJ: An immunoperoxidase study of senile cerebral amyloidosis with pathogenic considerations. J Neuropathol Exp Neurol 1981;40:592-612.
75. Schmidt ML, Lee VM, Trojanowski JQ: Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads. Lab Invest 1991;64:352-357.
76. Munoz DG: Chromogranin A-like immunoreactive neurites are major constituents of senile plaques. Lab Invest 1991;64:826-832.
77. Wisniewski HM, Wegiel J: Spatial relationship between astrocytes and classical plaque components. Neurobiol Ageing 1991;12:593-600.
78. Pike CJ, Cummings BJ, Monzavi R, Cotman CW: β-Amyloid induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 1994;63:517-531.
79. van Gool D, Strooper B, van Leuvan F, Triau E, Doni R: α2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease. Neurobiol Ageing 1993;14:233-237.
80. Haga S, Ikeda K, Sato M, Ishii T: Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement c3 component by cultured microglial cells. Brain Res 1993;601:88-94.
81. Das S, Potter H : Expression of the Alzheimer's amyloid promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 1995;14:447-456.
82. Kalaria RN, Kroon SN, Perry G: Serum proteins and the blood-brain barrier in the pathogenesis of Alzheimer's disease; in M Nicolini, M Zarta PF, Corain B (eds): Alzheimer's Disease and Related Disorders. Adv Biosci, vol 87. Oxford, Pergamon Press, 1993, pp 281-282.
83. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rose BL, Gasella JF, Crapper-MacLachan DR, Albersts MJ, Hulette C, Crain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
84. 1-antichymotrypsin and apolipoprotein e promote assembly of Alzheimer β-protein into filaments. Nature 1994;372:92-94.
85. Candy JM, McArthur FK, Oakley AE, Tayloer GA, Chen CPL, Mounfort SA, Thompson JE, Chalker PR, Bishop HE, Beyreuther K, Perry G, Ward MK, Martyn CN, Edwardson JA: Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure. J Neurol Sci 1992;107:210-218.
86. Landsberg JP, McDonald B, Watt F: Absence of aluminium in neuritic plaque cores in Alzheimer's disease. Nature 1992;360:65-68.
87. Hof PR, Morrison JH: Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. J Comp Neurol 1990;301:55-64.
88. Bell MA, Ball MJ: Neuritic plaques and vessels of visual cortex in ageing and Alzheimer's dementia. Neurobiol Ageing 1990;11:359-370.
89. Armstrong RA: Is the clustering of β-amyloid (Aβ) deposits in the frontal cortex of Alzheimer patients determined by blood vessels. Neurosci Lett 1995;195:121-124.
90. Armstrong RA: A comparison of β-amyloid (Aβ) deposition in the medial temporal lobe in late-onset sporadic Alzheimer's disease and Down's syndrome. Amyloid 1995;2:107-113.
91. Armstrong RA: The spatial patterns of β/A4 deposit subtypes and blood vessels in Alzheimer's disease cases with pronounced congophilic angiopathy. Neurosci Res Commun 1993;12:183-191.
92. Wisniewski HM, Wegiel J: β-Amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol 1994;87:233-241.
93. Yamaguchi H, Yamazaki Y, Lemere CA, Frosch MP, Selkoe DJ: Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. Am J Pathol 1992;141:249-259.
94. Armstrong RA, Cairns NJ, Patel R, Lantos PL, Rossor MM: Relationships between piamyloid (Aβ) deposits and blood vessels in patients with sporadic and familial Alzheimer's disease. Neurosci Lett 1996;207:171-174.
95. Kawai M, Kalaria RN, Harik SI, Perry G: The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol 1990;137:1435-1446.
96. Luthert PJ, Williams JA: A quantitative study of the coincidence of blood vessels and A4 protein deposits in Alzheimer's disease. Neurosci Lett 1991;126:110-112.
97. Perlmutter LS, Chang C: Microangiopathy, the vascular basement membrane and Alzheimer's disease: A review. Brain Res Bull 1990;24:677-686.
98. Mann DMA, Purkiss MS, Bonshik RE, Jones D, Brown AMT, Stoddart RW: Lectin histochemistry of cerebral microvessels in ageing. Alzheimer's disease and Down's syndrome. Neurobiol Ageing 1991;13:137-143.
99. Vinters HV, Pardridge VM: The blood-brain barrier in Alzheimer's disease. Can J Neurol Sci 1986;13:446-448.
100. Ohnishi S, Maeda S, Shimada K, Aroa T: Isolation and characterisation of the complete complimentary and genomic sequences of human serum amyloid P component. J Biochem 1986;100:849-858.
101. Tennant GA, Lovat LB, Pepys MB: Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer's disease and systemic amyloidosis. Proc Natl Acad Sci USA 1995;92:4299-4303.
102. Berr C, Hauw JJ, Deláere P, Duyckaerts C, Amouyel P: Apolipoprotein E allele e4 is linked to increased deposition of the amyloid β-peptide (Aβ) in cases with or without Alzheimer's disease. Neurosci Lett 1994;178:221-224.
103. Landen M, Thorsell A, Wallin A, Blennow K: The apolipoprotein E allele e4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996;61:352-356.
104. Iwamoto N, Nishiyama E, Ohwada J, Arai H: Distribution of amyloid deposits in the cerebral white matter of the Alzheimer's disease brain: Relationship to blood vessels. Acta Neuropathol 1997;93:334-340.
105. Giaccone G, Tagliavini F, Linoli G, Bouras C, Frigerio L: Down's patients: Extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett 1989;97:232-238.
106. Masliah E, Mallory M, Deerinck T, De Teresa R, Lamont S, Miller A, Terry RD, Carragher B, Ellisman M: Re-evaluation of the structural organisation of neuritic plaques in Alzheimer's disease. J Neuropathol Exp Neurol 1993;52:619-632.
107. Cummings BJ, Su JH, Cotman CW: Neuritic involvement wit in bFGF immunoreactive plaques in Alzheimer's disease. Exp Neurol 1993;124:315-325.
108. Canning DR, McKeon RJ, DeWhitt DA, Perry G, Wujek JR, Frederickson RCA, Silver J: β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp Neurol 1993;124:289-298.
109. Berkenbosch F, Refolo LM, Friedrich VL, Casper D, Blum M, Robakis NK: The Alzheimer's amyloid precursor protein is produced by type 1 astrocytes in primary cultures of rat neuroglia. J Neurosci Res 1990;25:431-440.
110. Cras P, Kawai M, Lowery D, Gonzalez de Whitt P, Greenberg B, Perry G: Senile plaque neurites in Alzheimer's disease accumulate amyloid precursor protein. Proc Natl Acad Sci USA 1991;88:7552-7556.
111. Mann DMA: The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev 1988;43:99-136.
112. Mann DMA, Yates PO, Marcyniuk B, Ravindra CR: The topography of plaques and tangles in Down's syndrome patients of different ages. Neuropathol Appl Neurobiol 1986;12:447-457.
113. Murphy CM, Eng LS, Ellis WG, Perry G, Meissner LC, Tinklenberg JR: Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: A comparison with Alzheimer's disease. Brain Res 1990;537:102-108.
114. Fraser PE, Nguyen JT, Surewicz WK, Kirschner DA: pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J 1991;60:1190-1201.
115. Fraser PE, Nguyen JT, Chin DT, Kirschner DA: Effects of sulfate ions on Alzheimer β/A4 peptide assemblies: Implications for amyloid fibril-proteoglycan interactions. J Neurochem 1992;59:1531-1540.
116. Lansbury PT Jr: In pursuit of the molecular structure of the amyloid plaque: New technology provides unexpected and critical information. Biochem 1992;31:6865-6870.
117. Khiavi-Ahzadeh K, Normand J, Chronopoulos S, Ali-Khan Z: Alzheimer's disease brain-derived ubiquitin has amyloid-enhancing factor activity: Behaviour of ubiquitin during accelerated amyloidogenesis. Acta Neuropathol 1991;81:280-286.
118. Carpenter MK, Crutcher KA, Kater SB: An analysis of the effects of Alzheimer plaques on living neurons. Neurobiol Ageing 1993;14:207-215.
119. Fraser PE, Levesque L, McLachlan DR: Alzheimer Aβ amyloid forms an inhibiting neuronal substrate. J Neurochem 1994;62:1227-1230.
120. Beiizing WC, Brady DR, Mufson EJ, Armstrong DM: Evidence that transmitter-containing dystrophic neurites precede those containing PHF within senile plaques in the entorhinal cortex of nondemented elderly and Alzheimer's disease patients. Brain Res 1993;619:55-68.
121. Tabaton M, Cammarata S, Mandybur T, Richey P, Kawai M, Perry G, Gambetti P: Senile plaques in cerebral amyloid angiopathy show accumulation of amyloid precursor protein without cytoskeletal abnormalities. Brain Res 1992;593:299-303.
122. Armstrong RA, Myers D, Smith CUM, Cairns N, Luthert PJ: The spatial pattern of senile plaques, neurofibrillary tangles and A4 deposits in Alzheimer's disease. Neurosci Res Commun 1992;10:27-33.
123. Allsop D, Kidd M, Landon M, Tomlinson A: Isolated senile plaque cores in Alzheimer's disease and Down's syndrome show differences in morphology. J Neurol Neurosurg Psychiatry 1986;49:886-892.
124. Braak H, Braak E, Kalus P: Alzheimer's disease: Areal and laminar pathology in the occipital isocortex. Acta Neuropathol 1989;77:494-506.
125. Probst A, Anderton BH, Brion JP, Ulrich J: Senile plaque neurites fail to demonstrate anti-paired helical filament and anti-microtubule protein-immunoreactive proteins in the absence of neurofibrillary tangles in the neocortex. Acta Neuropathol 1989;77:430-436.
126. Barcikowska M, Wisniewski HM, Bancher C, Grundke-Iqbal I: About the presence of paired helical filaments in dystrophic neurites participating in the plaque formation. Acta Neuropathol 1989;78:225-231.
127. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS: Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sci USA 1985;82:4531-4534.
128. Armstrong RA: Is the clustering of neurofibrillary tangles in Alzheimer's patients related to the cells of origin of specific cortico-cortical projections? Neurosci Lett 1993; 160: 57-60.